Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2025-06-30 12:37 Tx date 2025-06-27 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,965
+32,250 vol $0.34 each |
32,250 | |
Filed 2025-06-30 12:36 Tx date 2022-09-28 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2025-04-08 16:58 Tx date 2025-04-07 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+38,298 vol |
857,815 | |
Filed 2025-02-24 13:33 Tx date 2025-02-24 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+191,009 vol |
819,517 | |
Filed 2024-07-15 17:35 Tx date 2024-07-08 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+87,185 vol |
628,508 | |
Filed 2024-04-05 16:24 Tx date 2022-09-28 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-04-05 16:23 Tx date 2024-04-02 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+204,011 vol |
541,323 | |
Filed 2024-04-05 16:22 Tx date 2023-12-19 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+118,147 vol |
337,312 | |
Filed 2024-04-05 16:19 Tx date 2023-07-10 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+76,672 vol |
219,165 | |
Filed 2024-04-05 16:18 Tx date 2023-04-10 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+65,735 vol |
142,493 | |
Filed 2024-04-05 16:17 Tx date 2023-01-16 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+76,758 vol |
76,758 | |
Filed 2024-04-05 16:15 Tx date 2022-09-28 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-04-03 13:05 Tx date 2024-04-02 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+204,011 vol |
||
Filed 2024-01-02 12:01 Tx date 2023-12-19 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
10 - Acquisition or disposition in the public market
|
$6,249
+118,147 vol $0.0529 each |
||
Filed 2023-08-01 11:46 Tx date 2023-01-16 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+76,758 vol |
||
Filed 2023-08-01 11:45 Tx date 2023-07-10 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+76,672 vol |
||
Filed 2023-08-01 11:44 Tx date 2023-04-10 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+65,735 vol |
||
Filed 2023-01-18 14:38 Tx date 2023-01-16 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
97 - Other
|
+76,758 vol |
||
Filed 2023-01-18 14:35 Tx date 2022-09-28 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-04-03 13:05 Tx date 2024-04-02 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+204,011 vol |
541,323 | |
Filed 2024-01-02 12:01 Tx date 2023-12-19 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
10 - Acquisition or disposition in the public market
|
$6,249
+118,147 vol $0.0529 each |
337,312 | |
Filed 2023-08-03 11:20 Tx date 2023-07-28 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
Filed 2023-08-03 11:20 Tx date 2022-09-28 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-08-01 11:46 Tx date 2023-01-16 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+76,758 vol |
76,758 | |
Filed 2023-08-01 11:45 Tx date 2023-07-10 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+76,672 vol |
219,165 | |
Filed 2023-08-01 11:44 Tx date 2023-04-10 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+65,735 vol |
142,493 | |
Filed 2023-01-18 14:38 Tx date 2023-01-16 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
97 - Other
|
+76,758 vol |